Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Salvage radiotherapy after radical prostatectomy: outcomes and prognostic factors especially focusing on pathological findings.

Hayashi S, Hayashi K, Yoshimura R, Masuda H, Kihara K, Shibuya H.

J Radiat Res. 2012 Sep;53(5):727-34. doi: 10.1093/jrr/rrs034. Epub 2012 Jul 10.

2.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
3.
4.

Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.

Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):134-40.

PMID:
16111581
5.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

6.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
7.

Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy.

Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1411-7. Epub 2007 Feb 1.

PMID:
17275204
8.

Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.

Wadasaki K, Kaneyasu Y, Kenjo M, Matsuura K, Murakami Y, Hashimoto Y, Ito K, Kiriu H, Ito A.

Int J Clin Oncol. 2007 Feb;12(1):37-41. Epub 2007 Feb 25.

PMID:
17380439
9.

Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.

Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):112-8. doi: 10.1016/j.ijrobp.2011.10.077. Epub 2012 Jan 31.

PMID:
22300563
10.

Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy.

Tsien C, Griffith KA, Sandler HM, McLaughlin P, Sanda MG, Montie J, Reddy S, Hayman JA.

Urology. 2003 Jul;62(1):93-8.

PMID:
12837430
11.

Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy.

Tomita N, Kodaira T, Furutani K, Tachibana H, Nakahara R, Mizoguchi N, Hayashi N.

J Cancer Res Clin Oncol. 2009 Nov;135(11):1561-7. doi: 10.1007/s00432-009-0603-7. Epub 2009 May 29.

PMID:
19479278
12.

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.

Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):755-63.

PMID:
12788182
13.

Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.

King CR, Spiotto MT.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):23-7. doi: 10.1016/j.ijrobp.2007.09.047. Epub 2008 Jan 22.

PMID:
18207668
14.

Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes.

Do T, Dave G, Parker R, Kagan AR.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1220-5.

PMID:
11483332
15.

High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.

Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, De Meerleer G.

Eur Urol. 2011 Oct;60(4):842-9. doi: 10.1016/j.eururo.2011.04.021. Epub 2011 Apr 16.

PMID:
21514039
16.

Low pre-radiotherapy prostate-specific antigen level is a significant predictor of treatment success for postoperative radiotherapy in patients with prostate cancer.

Sasaki T, Nakamura K, Shioyama Y, Ohga S, Toba T, Urashima Y, Yoshitake T, Terashima H, Koga H, Naito S, Noma H, Komatsu K, Yamaguchi A, Hiratsuka Y, Hirano T, Hanada K, Abe M, Fujisawa Y, Honda H.

Anticancer Res. 2006 May-Jun;26(3B):2367-74.

17.

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.

Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M, Milosevic M.

Radiother Oncol. 2001 Apr;59(1):51-60.

PMID:
11295206
18.

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients.

Peyromaure M, Allouch M, Eschwege F, Verpillat P, Debré B, Zerbib M.

Urology. 2003 Sep;62(3):503-7.

PMID:
12946755
19.
20.

Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.

Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.

Cancer J Sci Am. 1998 Sep-Oct;4(5):324-30.

PMID:
9815297

Supplemental Content

Support Center